Published on

CDSCO Manufacturing License for Active implantable bone conduction hearing system

Authors
  • avatar
    Name
    CDSCO Licenses Blog
    Twitter

Introduction

The Central Drugs Standard Control Organization (CDSCO) is the key regulatory authority overseeing the pharmaceutical and medical devices industry in India. Their mandate extends to setting standards, controlling quality, approving new drugs and medical devices, and overseeing clinical trials, among other responsibilities.

Manufacturing licenses, governed by CDSCO, play a pivotal role in ensuring quality and safety in the production of medical devices. Given the potentially drastic health consequences from substandard products, securing these licenses provide an important gatekeeping function for the medical device industry.

In this blog post, we will be discussing the Active Implantable Bone Conduction Hearing System (IBCHS), a revolutionary device designed to compensate for conductive or mixed hearing losses. The IBCHS is a class C device that conveys amplified acoustic signals to the cochlea via mechanical vibrations on the skull bone. By providing a detailed walkthrough of the licensing process, this guide serves as a comprehensive resource to understand the steps required for manufacturing and distributing this critical medical technology.

More details about CDSCO and its regulatory framework can be found on their official portal.

What is Active Implantable Bone Conduction Hearing System?

The Active Implantable Bone Conduction Hearing System is a medical device precisely designed to support individuals who have hearing impairments. These devices work by translating ambient noise into vibrations, conducting these vibrations through the skull bone to stimulate the cochlear nerve directly. The end result of this innovative technology is to enhance hearing in individuals who have conductive or mixed hearing loss.

The primary advantage of the IBCHS over traditional hearing aids is that it bypasses the outer and middle ear. This allows sound to be conveyed directly to the cochlea, working around damaged or impaired ear structures that could impede successful acoustic transmission.

The Role of CDSCO in Medical Device Regulation

The CDSCO is an institution that is designed to ensure the safety, efficacy, and quality of drugs, cosmetics, diagnostics, and devices in India. The organization ensures that all medical devices, including the Active Implantable Bone Conduction Hearing System, meet stringent regulatory requirements before they are made available to the public.

CDSCO's Medical Devices Rules, 2017, provides the regulatory framework that guides the licensure, manufacture, distribution, and sales of medical devices in India. Under these rules, medical devices are classified according to their risk profile – from Class A (lowest risk) to Class D (highest risk). Our focus, the IBCHS, falls under Class C.

How to manufacture Active Implantable Bone Conduction Hearing System

The production of IBCHS devices involves rigorous processes that must conform to CDSCO regulations and guidelines. Essential documents, including a Device Master file, Quality Management Certificate, Device Details, and Site Details, must be properly prepared and submitted as part of your application for a manufacturing license.

Fees for manufacturing license for Active Implantable Bone Conduction Hearing System

Given that the IBCHS belongs to Class C, the applicable license is MD9. The fee structure for an MD9 license is Rs. 50,000 for the license and Rs. 1,000 per product.

Why is a Manufacturing License Necessary for Active Implantable Bone Conduction Hearing System?

A CDSCO manufacturing license is necessary for the following reasons:

  1. It is a mandatory requirement imposed by CDSCO.
  2. The license guarantees that the medical device meets the required standards of quality and safety.
  3. Ensures regulatory compliance, thereby protecting patients and consumers from substandard products.
  4. Upholds consumer confidence in the healthcare sector.

Steps to Obtain a CDSCO Manufacturing License for Active Implantable Bone Conduction Hearing System

Securing a CDSCO manufacturing license involves several steps:

  1. Prepare the necessary pre-requisites and documentation, including a Device Master File, Quality Management Certificate, Device Details, and Site Details.
  2. Submit the completed application through the appropriate CDSCO portal.
  3. The application undergoes review and scrutiny by the regulatory authority.
  4. Upon satisfactory review, the license is granted.

These steps may involve challenges that could slow down the approval process, including inadequate documentation, non-compliance with regulatory standards, or delays in responding to regulatory queries.

Frequently Asked Questions (FAQs)

Q1. What is risk class of Active Implantable Bone Conduction Hearing System as per Medical Device Rules, 2017?
The risk class for the Active Implantable Bone Conduction Hearing System is Class C.

Q2. What license is needed to manufacture Active Implantable Bone Conduction Hearing System?
To manufacture Active Implantable Bone Conduction Hearing System, an MD9 license is needed.

Q3. What is fees for MD9 license for Active Implantable Bone Conduction Hearing System?
The fees for an MD9 license is INR 50,000 and INR 1,000 per product.

Q4. Who will issue manufacturing license for Active Implantable Bone Conduction Hearing System?
The manufacturing license for Active Implantable Bone Conduction Hearing System, a Class C device, is issued by CDSCO HQ in New Delhi.

Q5. Is repackaging of Active Implantable Bone Conduction Hearing System considered manufacturing?
Yes, as per Drugs and Cosmetics Act's definition of manufacturing, repackaging of drugs is considered manufacturing. Medical devices are also drugs, by further definitions. Medical Device Rules have been made under the provisions of Drug Act only and hence repackaging of the Active Implantable Bone Conduction Hearing System is also considered manufacturing requiring an MD9 license.

Conclusion

The licensing process can be complex and daunting for many manufacturers. However, expert assistance is a click or a call away. PharmaDocx Consultants is a leading firm specializing in helping businesses secure their CDSCO licenses quickly and smoothly. You streamline the licensing process, ensuring your products are market-ready in the shortest possible time. For more information, visit "Pharmadocx", call +91-7404557227 or email [email protected].

Further, for issues concerning the MD9 license, you can refer to this article. It provides an in-depth understanding of the MD9 license and helps you navigate the licensing process.

References

cdsco import license in india banner
cdsco manufacturing license in india banner